Ticagrelor News
Ticagrelor currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Ticagrelor with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Brilique, co administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndromes (ACS) or a history of myocardial...
- Evidence level: L5
- Predicted indications (20):
- intracranial arteriosclerosis (100.0%)
- intermittent vascular claudication (100.0%)
- Monckeberg arteriosclerosis (99.9%)
- peripheral arterial disease (99.9%)
- peripheral vascular disease (99.9%)
- priapism (99.8%)
- ischemic disease (99.6%)
- May-Thurner syndrome (99.5%)
- livedo reticularis (99.5%)
- mesenteric vascular occlusion (99.5%)
- vascular ectasia (99.5%)
- angiodysplasia (99.3%)
- venous thromboembolism (99.3%)
- fibrocartilaginous embolism (99.3%)
- non-inflammatory vasculopathy (99.1%)
- erythromelalgia (99.1%)
- kyphoscoliotic heart disease (99.0%)
- congenital renal artery stenosis (99.0%)
- Prinzmetal angina (98.8%)
- vascular insufficiency disorder (98.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.